Ahli Majlis Unit Perundingan Universiti Malaya, University Malaya, 08-Aug-11 - 15-Aug-14

Ahli Majlis Penasihat Perubatan, Pusat Perubatan Universti Malaya, University Malaya, 30-Jul-11 - 30-Jun-14

Pengerusi, Jawatankuasa Latihan Bersama Ijazah Sarjana Psikiatri, National, 10-Jul-11 - 31-Dec-12

Ahli Jawatankuasa Etika Perubatan, Pusat Perubatan Universiti Malaya, University Malaya, 09-Jul-11 - 09-Oct-14

Penyelaras Program Sarjana Perubatan Psikologi, Department Of Psychological Medicine, Faculty Of Medicine, 09-Jul-11 - 30-Jun-14

Chairman for Exam Question Vetting Committee (Dept of Psychological Medicine), Department Of Psychological Medicine, Faculty Of Medicine, 09-Jul-11 - 30-Jun-14

Ahli Jawatankuasa Ubat-ubatan dan Therapeutik, Pusat Perubatan Universiti Malaya, University Malaya, 09-Jul-11 - 30-Jun-14

Internal Examiner for Post Graduate Exam, Master in Psychological Medicine, National, 03-Dec-07

Internal Examiner for MBBS Final Exam, Department Of Psychological Medicine, Faculty Of Medicine, 01-Jun-01

Penyelaras Unit Kajian Psikopharmakologi, Jabatan Perubatan Psikologi, Department Of Psychological Medicine, Faculty Of Medicine, 01-Jun-01 - 30-Jun-14

Psychiatry (Psychopharmacology)

M.H.Habil, R.Abdul Rashid & S.A.Jazaeri.2011.Perspectives of Addiction Medicine in Malaysia. 

Hussain Habil, Ahmad Hatim. Kemurungan: Punca dan rawatan. University Malaya Press. 2006 (Non-ISI/Non-SCOPUS Cited Publication)

National Methadone Maintenance Therapy Guideline. Ministry of Health Malaysia May 2005. 

Mas Ayu Said, A Hatim, MH Habil, Wan Zafidah, Haslina MY, Badiah Y, Ramli MA, Ananjit S, Sapini Y, Mohd Shah, Badli Mahmud, Awang Bulgiba, Noran N Hairi. Metabolic syndrome and monotherapy antipsychotic treatment among schizophrenia patients in Malaysia. Preventive Medicine. (Tier 1; Impact Factor = 3.2) (Accepted for publication on 11 January 2013) (ISI-Cited Publication)

Ahmad Hatim Sulaiman, Mas Ayu, Mohd Hussain Habil, Rusdi Rashid, Amer Siddiq, Ng Chong Guan, Marhani Midin, Nik Ruzyanei Nik Jaafar, Hatta Sidi, Srijit Das.The Risk and Associated Factors of Methamphetamine Psychosis in Methamphetamine Dependent Patients in Malaysia. Comprehensive Psychiatry.(Tier 2; Impact Factor = 2.2) (Accepted for Publication 20 Jan 2013) (ISI-Cited Publication)

M.S.Sim, A.Hatim, G.P.Reynolds, Z.Mohamed. Association of a functional polymorphism in the FAAH gene with methamphetamine dependence and methamphetamine-induced symptoms in a Malaysian population. Pharmacogenomics. (Tier 1; Impact Factor = 3.97) (accepted for publication 17 Jan 2013) (ISI-Cited Publication)

Ahmad Hatim Sulaiman, Jesjeet Singh Gill, Mas Ayu Said, Nor Zuraida Zainal, Mohad Hussain Habil, Ng Chong Guan. Non-Psychotic Psychiatric Co-Morbidities in Patients with Methamphetamine Dependence in Malaysia. International Medical Journal.(Accepted for Publication) (ISI-Cited Publication)

Sulaiman AH, Gill JS, Said MA, Zainal NZ, Hussein HM, Guan NC.2012. A Randomized, Placebo- Controlled Trial of Aripiprazole For The Treatment Of Methamphetamine Dependence and Associated Psychosis. International Journal of Psychiatry in Clinical Practice, 2012;Early Online: 1-8. doi:10.3109/13651501.2012.667116. (ISI-Cited Publication)

Vieta E, Montgomery S, Sulaiman AH, Cordoba R, Huberlant B, Martinez L, Schreiner A. 2012. A randomized, double-blind, placebo-controlled trial to assess prevention of mood episodes with risperidone long-acting injectable in patients with bipolar I disorder. Eur Neuropsychopharmacol. 2012;22(11):825- 835. (Tier 1; Impact Factor = 4.0) (ISI-Cited Publication)

Coppola D, Liu Y, Gopal S, Remmerie B, Samtani MN, Hough DW, Nuamah I, Sulaiman AH, Pandina G. 2012. A one-year prospective study of the safety, tolerability and pharmacokinetics of the highest available dose of paliperidone palmitate in patients with schizophrenia. BMC Psychiatry,2012 Mar 28;12(1):26. (Tier 2; Impact Factor = 2.5) (ISI-Cited Publication)

Ahmad Hatim Sulaiman, Jesjeet Singh Gill, Mas Ayu said, Mohamad Hussain habil, Nor Zuraida Zainal, Chong Guan Ng. 2012. An open label study of aripiprazole for methamphetamine induce psychosis. Bulletin of Clinical Psychopharmacology.2012;22(2):121-9 (ISI-Cited Publication)

Ahmad Hatim Sulaiman, Mas Ayu Said, Srijit Das. Substance use, sexual intercourse, and condom non-use among depressed adolescents and young adults: scientific views.Journal of Adolescent Health, 2012;50:654-655. (Tier 1; Impact Factor = 3.3) (ISI-Cited Publication)

Mas Ayu Said, Ahmad Hatim Sulaiman, Mohd Hussain Habil, Srijit Das, Abdul Kadir Abu Bakar, Rosliwati Md. Yusoff, Loo Tsui Huei, Shamshunnisah Abu Bakar. Metabolic syndrome and cardiovascular risk among schizophrenia patients receiving antipsychotics in Malaysia. Singapore Medical Journal,2012;53(12):801-807 (ISI-Cited Publication)

Ng Chong Guan, Marco PM Boks, Ahmad Hatim Sulaiman, Nor Zuraida Zaina, Niek J De Wit. (2013). Diagnostic Criteria for Major Depressive Disorder in Cancer Patients; a review. International Journal of Psychiatry in Medicine. 45(1): 73-82. (ISI-Cited Publication)

Ahmad Hatim Sulaiman, Mas Ayu Said, Srijit Das. An insight on career satisfaction level, mental distress, and gender differences in working conditions among Japanese Obstetricians and Gynecologists. The Journal of Obstetrics and Gynaecology Research, 2012. doi:10.1111/j.1447-0756.2012.01966.x (Early online publication) (ISI-Cited Publication)

A. Hatim, S. Mas Ayu, H. Habil, M. Mustafa, J. Gill, R. Rusdi and A. Amer Siddiq. Psychiatric co-morbidity and suicidality among methamphetamine dependent patients who seek treatment in Malaysia. European Neuropsyhopharmacology, 2011,21(2): S161 (ISI-Cited Publication)

4.Rusdi Abd. Rashid, Noor Zurani Md Haris Robson, Ahmad Hatim Sulaiman, Rabaiah Salleh, Nor Zuraida Zainal, Mas Ayu Said, Mohammad Hussain Habil. Schizophrenia, Substance use and aggressions: What are the relationships? Online Journal ASEAN Journal of Psychiatry. Vol. 11(1): Jan-June 2010. (Non-ISI/Non-SCOPUS Cited Publication)

Noor Zurani Md Haris Robson, Stephen Jambunathan, Jesjeet S Gill, Ahmad Hatim Sulaiman, Mohammad Hussain Habil. Research, casuistry and psychiatry An Asian perspective. Asean Journal of Psychiatry, Vol.11(1): Jan June 2010: 2-5 (Non-ISI/Non-SCOPUS Cited Publication)

Mas Ayu S, Lai LR, Chan YF, Hatim A, Hairi NN, Ayob A, Sam IC. Seroprevalence survey of Chikungunya virus in Bagan Panchor, Malaysia. American Journal of Tropical Medicine and Hygiene 2010; 83(6):1245-1248. (Tier 2; Impact Factor = 2.5) (ISI-Cited Publication)

Maw Shin Sim,Zahurin Mohamed,Ahmad Hatim,Vijaya Lejchimi Rajagopal,Mohamad Hussain Habil.2010. Association of brain-derived neurotrophic factor (Val66Met)genetic polymorphism with methamphetamine dependence in a Malaysian population. Brain Research (1357):91-96 (ISI-Cited Publication)

Ahmad Hatim. Is the patient really the same after a major depressive episode? Medicographia. April 2009: Volume 31(2): 9 10 (Non-ISI/Non-SCOPUS Cited Publication)

Q.Q. Ang, Y.K. Wing, Y. He, A.H. Sulaiman, N.Y. Chiu, Y.C Shen, C. Zhang, K.H. Lee, P. Singh, R.E. Granger,J. Raskin, M. Dossenbach. 2009. Association between painful physical symptoms and clinical outcomes in East Asian patients with major depressive disorder: a 3-month prospective observational study.The International Journal of Clinical Practice 63 (7):1041-1049. (Tier 1; Impact Factor = 2.4) (ISI-Cited Publication)

David M. Clarke, Ahmad Hatim, Brian Ho, Jiyang Pan, Chee Ng, Kang-Seob Oh, Wu Wenyuan, Mak Ki-Yan. Somatic Symptoms of Depression and Anxiety in the Western Pacific Region: Questions and Answers. CNS Spectr. 2009;14(4):1-8 (ISI-Cited Publication)

A Hatim, J Tan,Mas Ayu, H Habil. Service utilization and costs associated with switching to risperidone from previous treatment with typical antipsychotics agents.Malaysian Journal of Psychiatry online early 2.4.2009:1-13 (Non-ISI/Non-SCOPUS Cited Publication)

A Hatim, JS Gill, TH Yen, M Ariff, OM Lemming, MZ Azhar. Escitalopram in the Treatment of Malaysian Patients with Obsessive-compulsive Disorder. Hong Kong Journal of Psychiatry. December 2008: Volume 18 (4): 152 157 (SCOPUS-Cited Publication)

Sharmilla T, Ahmad Hatim S, Jambunathan ST. Prevalence of obesity, lipid and glucose abnormalities in outpatients prescribed clozapine in UMMC Kuala Lumpur. Malaysian Journal of Psychiatry. December 2008: 17(2): 37 46 (Non-ISI/Non-SCOPUS Cited Publication)

Ahmad Hatim S. Amphetamine type stimulant psychosis: a rising problems in Malaysia. Malaysian Journal of Psychiatry. December 2008: 17(2): 3 6 (Non-ISI/Non-SCOPUS Cited Publication)

Jesjeet Singh Gill, Ahmad Hatim Sulaiman, Mohd Hussain Habil. The first methadone programme in Malaysia:overcoming obstacles and achieving the impossible. Asean Journal of Psychiatry., December 2007: Volume 8, 64-70 (Non-ISI/Non-SCOPUS Cited Publication)

Zuraida NZ, Ahmad HS. Religiosity and suicide ideation in clinically depressed patients. The Malaysian Journal of Psychiatry, March 2007: 16: 12-15 (Non-ISI/Non-SCOPUS Cited Publication)

Hatim A, Yen TH. Drug utilization patterns and outcomes associated with in-hospital treatment with risperidone and olanzapine: a naturalistic study in UMMC. Journal of University Malaya Medical Centre. 2006:Volume 9 (1), 23-29 (SCOPUS-Cited Publication)

Pillai SK, Ahmad HS, Jesjeet SG, Jambunathan ST. Psychiatric posting in final year medical students: do attitudes change? The Malaysian Journal of Psychiatry, September 2006: 15:26-31. (Non-ISI/Non-SCOPUS Cited Publication)

Sharmilla K, Ahmad HS. A comparison of insight in schizophrenia, bipolar affective disorder with psychosis and major depression with psychosis. The Malaysian Journal of Psychiatry, March 2006: 14: 35-40 (Non-ISI/Non-SCOPUS Cited Publication)

Hatim A, Habil H, Jesjeet SG, Low CC, Joseph J, Jambunathan ST, Zuraida NZ. Safety and efficacy of rapid dose administration of quetiapine in the treatment of bipolar mania. Human Psychopharmacology: Clinical and Experimental, July 2006: Volume 21, 313- 318. (Tier 2; Impac factor = 2.4) (ISI-Cited Publication)

Hatim A, Yen TH. Drug utilization patterns and outcomes associated with in-hospital treatment with risperidone and olanzapine: a naturalistic study in UMMC. Journal of University Malaya Medical Centre. 2006:Volume 9 (1), 23-29 (Non-ISI/Non-SCOPUS Cited Publication)

Hang TJ, Hatim A. Insight among patients with schizophrenia in Hospital Permai. The Malaysian Journal of Psychiatry, March 2004: 12: 32-37 (Non-ISI/Non-SCOPUS Cited Publication)

Hatim A, Zuraida A, Tan KS, Tan CT. Prevalence and Associations of Post Stroke Depression. Neurological Journal of South East Asia, December 2002: 7: 71-75. (Non-ISI/Non-SCOPUS Cited Publication)

Mas A, Hatim A.Stigma in Mental Illness: Attitudes of Medical Students Towards Mental Illness, 2002, Med. J. Malaysia, Vol. 57, no. 4, pg. 427-438 (ISI/SCOPUS Cited Publication)

Hatim A, Yen TH. The Efficacy and Outcome of Clozapine Usage in Treatment Resistant Schizophrenic Patient in University Malaya Medical Centre. The Malaysian Journal of Psychiatry, September 2001: 9(2): 6-9. (Non-ISI/Non-SCOPUS Cited Publication)

Hatim A, Hussain H. General Practitioners View About Treating Schizophrenic Patients in General Practice Settings. The Malaysian Journal of Psychiatry, March 2001: 9(1): 43-47. (Non-ISI/Non-SCOPUS Cited Publication)

M. Said, A.H. Sulaiman, M.H. Habil. 2011. Aripiprazole treatment effects on metabolic syndrome parameters in schizophrenia patients: preliminary results. European Psychiatry. Volume 26, Suppl 1. page (ISI-Cited Publication)

Sim, Maw Shin; Sulaiman, Ahmad Hatim; Jaafar, Ahmad Nur Fayyadh Ahmad; et al. 2011. Association of SOD2 (superoxide dismutase 2) genetic polymorphisms with methamphetamine dependence in Malaysian population. Drug Metabolism Reviews Volume: 43 Pages: 69-70. (ISI-Cited Publication)

Said, M. A.; Sulaiman, A. H.; Habil, M. H. Ziprasidone treatment effects on lipids in patients with metabolic risk: preliminary results. European Psychiatry Volume: 25, page (ISI-Cited Publication)

Thavichachart, N.; Conde, B.; Sobrevega, E.; et al. Efficacy and tolerability study of flexibly dosed paliperidone ER in ASEAN schizophrenia patient who previously unsuccessfully treated with other oral antipsychotics . International Journal of Neuropsychopharmacology Volume: 13 Pages: 243 (ISI-Cited Publication)

Hatim A, Ayu M, Habil H. Psychiatric co-morbidity among patients with amphetamine and metamphetamine dependence in Malaysia. European Neuropsychopharmacology Volume: 19 Pages: S654-S655 (ISI-Cited Publication)

Hatim A, Ayu M, Mustafa M, Habil H. Safety and efficacy of aripiprazole in the treatment of amphetamine and methamphetamine induce psychosis: A preliminary results. The World Journal of Biological Psychiatry. 2009; 10 (supp 1): 403 (ISI-Cited Publication)

A. Hatim, M Ayu, H Habil, JT Tan. Service utilization and cost associated with switching to risperidone from previous treatment with typical antipsychotic agents. International Journal of Neuropsychopharmacology Volume: 11 Pages: 158-159 (ISI-Cited Publication)

282-283Said, MA; Sulaiman, AH; Yen, T; et al. Subgroup analysis of Malaysian patients in a randomised, placebo-controlled relapse-prevention study with escitalopram in obsessive-compulsive disorder. International Journal of Neuropsychopharmacology Volume: 11 Pages: 282-283 (ISI-Cited Publication)

Ahmad Hatim. Psychiatric posting in final year medical students: do attitudes change? World Psychiatric Association Regional Meeting. Seoul, Korea. April 18 21, 2007. (Non-ISI/Non-SCOPUS Cited Publication)

Ahmad Hatim, Hussain Habil, Mas Ayu. The use of buprenorphine in the treatment of opiate dependence in Malaysia. XIII World Congress of Psychiatry. Cairo, Egypt. 10-15 September 2005 (Non-ISI/Non-SCOPUS Cited Publication)

Gill JS, Koh OH, Hatim A, Jambunathan ST. First episode psychosis: cultural differences in Malaysia. Schizophrenia Research, September 2004:Vol 70 (Suplement 1):81 (ISI-Cited Publication)

Said, MA; Sulaiman, AH; Gill, JS. 2004. Diabetes mellitus, obesity and lipid abnormalities in schizophrenic patients treated with atypical antipsychotics. International Journal of Neuropsychopharmacology Volume: 7 Pages: S255. (ISI-Cited Publication)

Gill JS, Jambunathan ST, Low CC, Jacob J, Hatim A. Implementing an Early intervention programme that caters to the need of the multicultural population in Malaysia. Schizophrenia Research, September 2004:Vol 70 (Suplement 1):29 (ISI-Cited Publication)

M Ayu, A Hatim, S Norriah. Risk Factors of Major Depression Among the Post Stroke Patients: A Hospital Based Case-Control Study At University Malaya Medical Centre. The 34th Asia Pacific Academic Consortium for Public Health Conference. Kuala Lumpur, Malaysia. 17- 20 July 2002: page 22 (Non-ISI/Non-SCOPUS Cited Publication)

A Hatim, A Mas. Stigma in Mental Illness: Attitudes of Medical Students Towards Mentally Ill Patient. XII World Congress of Psychiatry. Yokohama, Japan. 24 29 August 2002: volume 2: 169 (Non-ISI/Non-SCOPUS Cited Publication)

A Hatim, N Zuraida, KS Tan, CT Tan. Study of Post Stroke Depression in University Malaya Medical Centre Kuala Lumpur. 4th Biennial Convention of The ASEAN Neurological Association. Kuala Lumpur, Malaysia. 22- 24 March 2001: page 94. (Non-ISI/Non-SCOPUS Cited Publication)

A Hatim, N Zuraida. Prevalence and Clinical Determinants of Post Stroke Depression.7th World Congress of Biological Psychiatry. Berlin, Germany. 1- 6 July 2001. (Non-ISI/Non-SCOPUS Cited Publication)

TV9. Nasi Lemak Kopi O. Masalah penderaan kanak-kanak. 20th February 2011. 

Ajar seks bermula di rumah. I Luv Islam. 22 Oktober 2010. mukasurat 10. 

Kesedaran perlu ada untuk berubah. I Luv Islam. 31 Disember 2010. Mukasurat 8. 

Kesan penagihan methamphetamine. China Press. 2010 

TV3. Malaysia Hari Ini. Anger Management. 16th January 2009 

Don t let anxiety ruin your life. New Straits Times. Life and Times; 20th January 2009: page 8-9. 

Penagih dadah sintetik sering hilang pertimbangan. Berita Minggu. 6th September 2009. page 3. 

RTM: TV2. Social Phobia. 17th July 2007 

TV9. Rancangan Keluarga di 9: Penyakit Bipolar. 24th December 2007. 

Nescafe Kickstart Dream Job . 22nd January 2006. 

TV2 (National Television). Antisocial personality disorder. 16th March 2006 

Gila Meroyan (Post-partum Psychosis). Berita Minggu. 7th May 2006 

TV3 (Wanita Hari Ini). Kemurungan (Depression). 13th June 2006. 

Mangsa Tsunami perlu diberikan sokongan moral. Ruangan Wawancara. Mingguan Malaysia. 2 Januari 2005, mukasurat 7 

SAKA, sekadar gangguan mental. Berita Harian . 1 Mei 2005. page 22 

New hope for addicts. New Straits Times. March 31, 2004: page 9 

Treating addiction as a medical condition. Health Today Magazine. April 2004: page 39. 

Rawatan selamat kikis ketagihan dadah. Berita Harian. April 8, 2004. 

Rancangan: Cegah Dan Rawat. April 19, 2004 

Unsur ganas galak tingkah laku agresif. Mingguan Malaysia. Mei 23, 2004 

Hit by hysteria. Sunday Mail May 23, 2004 

Mimpi ngeri misteri ganguan tidur. Ruangan Kesihatan, Mingguan Malaysia. 7 November 2004. Mukasurat 25. 

Psychiatrist s sofa is not all that bad. The New Sunday Times. Jan 19, 2003: page F4 

Masyarakat masih kurang kesedaran penyakit skizophrenia. Berita Harian. September 12, 2003: page C13. 

Befriending the depressed. The New Sunday Times. June 16, 2002: page F4 

A phase 3, multicentre, randomized, double blinf, placebo conttrolled study of the efficacy and safety of ALKS 9072 in subjects with acute exacerbation of schizophrenia, Principal Investigator(PI), 2012-2014, ALKERMES, INC (United States of America), International

Efficacy and safety of escitalopram in diabetic patients with major depression., Principal Investigator(PI), 2011-2012, Geran Penyelidikan Universiti Malaya (UMRG), National

An Open-Label, Multicenter, Rollover, Long-term Study of Aripiprazole Intramuscular Depot in Patients with Schizophrenia, Principal Investigator(PI), 2011-2018, Otsuka Pharmaceutical Development (United States of America), International

Study of the efficacy and safety of dapoxetine in men with premature ejaculation and concomitant erectile dysfunction treated with a phosphodiesterase -5 inibitor., Principal Investigator(PI), 2011-2012, Janssen Cilag, International

Randomized controlled trial of the safety and efficacy of aripiprazole versus ziprazidone in schizophrenic patients with metabolic syndrome and diabetes mellitus, Principal Investigator(PI), 2010-2012, Pfizer Sdn Bhd, National

The association study of various genetic polymorphisms and drug addiction to stimulants in Malaysian populations, Principal Investigator(PI), 2009-2010, Geran Penyelidikan Universiti Malaya (UMRG), National

Recognising ethnic differences in depression - a multinational, observational study to detect potential differences in depression in various asian populations., Principal Investigator(PI), 2009-2011, Lundbeck (Denmark), International

A one year prospective study of safety, tolerability and pharmacokinetics of the highest avaialable dose of paliperidone palmitate in patients with schizophrenia, Principal Investigator(PI), 2008-2010, Janssen Cilag (United States of America), International

Depression, Principal Investigator(PI), 2008, 

Psychopharmacology, Principal Investigator(PI), 2008, 

Schizophrenia, Principal Investigator(PI), 2008, 

Seroprevalence survey of Chikungunya virus in Bagan Panchor Malaysia, Co-Investigator, 2008-2009, Short Term Research Fund (Vote F)(PJP), National

A randomized, double-blind, placebo-controlled trial to assess prevention of mood episodes with risperidone long-acting injectable in patients with bipolar I disorder, Principal Investigator(PI), 2008-2009, Janssen Cilag (Europe), International

Bipolar Disorder, Principal Investigator(PI), 2008, 

An open-label prospective trial to explore tolerability, safety and efficacy of flexible dosed paliperidone ER in subjects with schizophrenia, Principal Investigator(PI), 2008-2009, Janssen- Cilag, International

Association between genetic polymorhism with drug addiction to stimulants, Principal Investigator(PI), 2007-2008, Short Term Research Fund (Vote F)(PJP), National

Randomised, double-blind, parallel-group, placebo- controlled, duloxetine referenced, dose-finding study of Lu AA24530 in Major Depressive Disorder., Principal Investigator(PI), 2007-2009, Lundbeck (Denmark), International

A phase IIA, randomized, double blind, placebo controlled, 2 period, cross over clinical trail to study the safety and efficacy of MK 0557 for the treatment of cognitive impairment in patients with schizophrenia, Principal Investigator(PI), 2007-2009, Merck Sharp and Dohme (MSD) (USA), International

Escitalopram in the treatment of Malaysian patients with obsessive compulsive disorder, Principal Investigator(PI), 2006-2007, Lundbeck (Denmark), National

Safety and efficacy of rapid dose administration of quetiapine in bipolar mania, Principal Investigator(PI), 2005-2006, Astra Zeneca Pharmaceutical, National

Risperidone and olanzapine in patient utilization in the University of Malaya Medical Centre, Kuala Lumpur, Principal Investigator(PI), 2005-2006, Janssen Cilag, National

Methadone treatment for herion dependence in Malaysia., Co-Investigator, 2005-2006, Duopharma Pharmaceutical, National

Scientific Coordinator, Consultant, 2012-2014, Institut De Recherches Internationales Servier

Chairman, Data safety Monitoring Board, Consultant, 2012-2014, Mitshubishi Tanabe Pharma Corporation

Consultancy Services, Consultant, 2012-2013, H. Lundbeck A/S

Consultant to Substance Abuse and Research Centre, Consultant, 2012-2014, Substance Abuse and Research Centre, Jazan University, Saudi Arabia

A multicenter, active-controlled double-blind, parallel group comparison trial to investigate the efficacy and safety of aripiprazole intramuscular depot (opc-14597imd) compared with aripiprazole tablet in patients with schizophrenia), Consultant, 2011-2013, Otsuka Pharmaceutical Japan

A 3-weeks, open label study to evaluate the efficacy in agitation and safety of quetiapine fumarate (seroquel xr) in the treatment of patients with acute schizophrenia., Consultant, 2009-2010, Astra Zeneca Pharmaceutical

A randomized, double-blind, parallel-group, placebo-controlled, fixed-dose study comparing the efficacy and safety of 3 doses of lu aa21004 in acute major depression., Consultant, 2009-2013, Takeda

A prospective, observational study comparing the frequency of treatment-emergent sexual dysfunction over 8 weeks in patients with major depressive disorder treated with either duloxetine hydrochloride or a selective serotonin reuptake inhibitor antidepressant and evaluated for 6 months, Consultant, 2009-2010, Eli Lilly Sdn Bhd

A prospective, randomized, active controlled, rater blinded study of the prevention of relapse comparing palmitate with oral risperidone in adults with recently diagnosed schizophrenia who are at high risk of relapse., Consultant, 2009-2010, Janssen Cilag

A phase 3 randomized, placebo-controlled, clinikal trial to study the safety and efficacy of three doses of lurasidone hcl in acutely psychotic patients with schizophrenia., Consultant, 2008-2010, Danippon Sumitomo

A one year multi national, multi centre, randomized, double blind, parallel group, fixed dose, bifeprunox study combining a 12 week placebo., Consultant, 2008-2012, Lundbeck

Pharmacoepidemiologic International Longitudinal Antipsychotic Registry (PILLAR), Consultant, 2008-2010, Janssen Cilag

A multicenter, randomized, double-blind, placebo-controlled, parallel grou-comparison trial of aripiprazole in the treatment of patients with bipolar disorder experiencing a manic or mixed episode, Consultant, 2008-2011, Otsuka Pharmaceutical Japan

A single dose, open-label, randomized, parallel group safety to assess the pharmacokinetic, safety and tolerability of a paliperidone palmitate 3 monthly formulation., Consultant, 2008-2012, Janssen Cilag

Coordinating Investigator, Consultant, 2007-2010, Lundbeck A/S

A randomized double-blind, placebo controlled, parallel-group dose response study to evaluate the efficacy and safety of 3 fixed doses of paliperidone palmitate in subjects with schizophrenia, Consultant, 2007-2009, Janssen Cilag

A randomized,double blind,placebo controlled,parallel group study to evaluate the efficacy and safety of flexible dose paliperidone ER in the treatment of subject with schizoaffective., Consultant, 2007-2009, Quintiles East Asia

A multi-national, multi-center, double-blind, placebo-controlled, parallel group, fixed dose efficacy and safety study of SR58611a 350 mg twice daily vs placebo in adult with major depression., Consultant, 2007-2010, Sanofi Aventis

Efficacy and safety of 2mg/ day of M100907 on sleep maintenance insomnia with a sub study of the effect of M100907 on stable type ii diabetes mellitus : a one year, multi centre, randomized, double blind, placebo controlled study., Consultant, 2007-2009, Sanofi Aventis

A double-blind, randomized, parallel-group, placebo controlled study of the safety, tolerability and efficacy following sequential dose regimens of Lu 31-130 in male schizophrenia., Consultant, 2007-2010, Lundbeck

A six week, double blind, placebo-controlled phase iii trial evaluating the efficacy, safety and pharmacokinetics of flexible doses of oral ziprazidone in adolescent subject with schizophrenia., Consultant, 2006-2010, Pfizer

Scientific National Coordinator, Consultant, 2006-2009, Institut De Recherches Internationales Servier (IRIS)

Advisory Board Member, Consultant, 2006-2008, Wyeth Pharmaceutical Inc

Safety, tolerability and treatment response of paliperidone palmitate in subjects with schizophrenia when switching from oral antipsychotics., Consultant, 2006-2008, Janssen Cilag

Pengarang Buku Terlaris 2007, Penerbitan Universiti Malaya, 2008, (UNIVERSITY)

Sijil Khidmat Cemerlang, Universiti Malaya, 2006, (UNIVERSITY)

Sijil Perkhidmatan Cemerlang, Universiti Malaya, 2005, (UNIVERSITY)

Anugerah Khidmat Cemerlang, Universiti Malaya, 2004, (UNIVERSITY)

Best Research Paper Competition, Malaysian Psychiatric Association, 2004, (NATIONAL)

Best Psychiatrist Trainee Award, Malaysian Psychiatric Association, 2001, (NATIONAL)

Managing Broad Symptoms of Major Depressive Disorder, 9th Perak Mental Health Convention, 09 Oct 2012 to 10 Oct 2012, Hospital Bahagia Ulu Kinta, (National)

Managing bipolar disorder from acute to maintenance: focusing on patient outcomes, Symposium: Galvanizing the exploration of mental health conundrums of the young, adults and the elderly, 14 Oct 2011 to 15 Oct 2011, Pertubuhan Pendidikkan Psikiatri Taiping, (National)

Atypical antipsychotics in mood disorders, 13th Johor Mental Health Conference, 20 May 2011 to 21 May 2011, Hospital Permai Johor, (National)

Unmet needs of Bipolar and Schizophrenia, Unveiling the untypical, 23 Oct 2011 to 23 Oct 2011, Lundbeck Malaysia, (National)

Addiction Psychiatry, 12th Johor Mental Health Convention, 31 May 2010 to 02 Jun 2010, Hospital Permai Johor Bharu, (National)

Atypical antipsychotic usage in Malaysia., Collegium International Neuropsychopharmacology (CINP) Regional Conference, 02 Mar 2008 to 05 Mar 2008, Collegium International Neuropsychopharmacology, (International)

Remission in depression, 3rd Sarawak Mental Health Conference, 06 Aug 2009 to 08 Aug 2009, Hospital Sentosa Kuching, (National)

Metabolic syndrome in schizophrenia, 8th Perak Mental Health Convention, 08 Oct 2010 to 10 Oct 2010, Hospital Bahagia Ulu Kinta, (National)

Rating Rules for Hamilton Anxiety Scale, Asian Investigators Meeting, 15 Nov 2012 to 16 Nov 2012, Servier Pharmaceutical and Quintiles East Asia, (International)

Recognizing and managing depression in primary care, 4th Perak Health Conference 2011, 16 May 2011 to 18 May 2011, Malaysian Association of Public Health Physicians and Perak State Health Department, (National)

Psychiatric posting in final year medical students: do attitudes change?, World Psychiatric Association Regional Meeting., 18 Apr 2007 to 21 Apr 2007, World Psychiatric Association, (International)

PANSS National Language Trainer, COMPASS Schizophrenia Investigators Meeting, 20 Oct 2012, Otsuka Pharmaceutical and Bracket Global, (International)

Paradigm shift in treatment goals for Depression and Anxiety, 4th Sabah MEntal Health Conference, 22 May 2008 to 24 May 2008, Hospital Mesra Bukit Padang, (National)

The scourge about designer drugs, 6th National Conference on Addiction Medicine, 23 Oct 2010 to 25 Oct 2010, Addiction Medicine Association of Malaysia, (National)

Managing Metabolic Syndrome in Schizophrenia, 12th Congress of ASEAN Federation for Psychiatry and Mental Health, 24 Jun 2010 to 26 Jun 2010, ASEAN Federation for Psychiatry and Mental Health, (International)

FDA inspection in Malaysia, US FDA Inspection: Experience Sharing Seminar, 24 Nov 2009 to 24 Nov 2009, Quintiles, (International)

Methamphetamine psychosis, Seminar: Substance Abuse Perils, 25 Apr 2010 to 25 Apr 2010, Malaysian Medical Association, (National)

Wellness program, 7th Kuala Lumpur Mental Health Conference, 26 Jul 2010 to 28 Jul 2010, Badan Kebajikan Psikiatri Hospital Kuala Lumpur, (National)

Administering and rating the MADRS, Investigators Meeting for Study 13926A, 27 Jul 2012 to 29 Jul 2012, Lundbeck, (International)

Management of schizophrenia, Workshop: Management of Psychosis, 28 Oct 2009 to 28 Oct 2009, Hospital Sultanah Bahiyah, (National)

How to improve adherence in Bipolar Affective Disorder? Problems and Solutions in Asian Countries, The Bipolar Education Training in Asia Forum 2011, 28 Oct 2011 to 29 Oct 2011, Society for Advancement of Bipolar Affective Disorder, (International)

Safety and efficacy of rapid dose administration of quetiapine in bipolar mania., ISS Investigators Meeting, 29 Nov 2006 to 01 Dec 2006, Astra Zeneca, (International)

The use of buprenorphine in the treatment of opiate dependence in Malaysia, XIII World Congress of Psychiatry., 10 Sep 2005 to 15 Sep 2005, World Psychiatry Association, (International)

Aripirazole treatment effects on metabolic syndrome parameters in schizophrenia patients: preliminary results, 19th European Congress of Psychiatry, 12 Mar 2011 to 15 Mar 2011, European Psychiatry Association, (International)

Prevalence of psychiatric co-morbidity and suicidality among methamphetamine dependence patients., 11th European Collegium Neuropsychopharmacology (ECNP) Regional Meeting, 14 Apr 2011 to 16 Apr 2011, European Collegium Neuropsychopharmacology (ECNP), (International)

Study of Post Stroke Depression in University Malaya Medical Centre Kuala Lumpur, 4th Biennial Convention of The ASEAN Neurological Association, 01 Apr 2001

Stigma in Mental Illness: Attitudes of Medical Students Towards Mentally Ill Patient, XII World Congress of Psychiatry, 01 Apr 2002

The use of buprenorphine in the treatment of opiate dependence in Malaysia, XIII World Congress of Psychiatry, 01 Apr 2005

Service utilization and cost associated with switching to risperidone from previous treatment with typical antipsychotic agents., XXVI Collegium International Neuropsychopharmacology (CINP) Congress, 01 Apr 2008

Psychiatric co-morbidity among patients with amphetamine and metamphetamine dependence in Malaysia., 22nd European College of Neuropsychopharmacology Congress, 01 Apr 2009

Safety and efficacy of aripiprazole in the treatment of amphetamine and methamphetamine induce psychosis: A preliminary results., 9th World Congress of Biological Psychiatry, 01 Apr 2009

Ziprasidone treatment effects on lipids in patients with metabolic risk: preliminary results., 18th European Congress of Psychiatry, 01 Apr 2010

Aripiprazole treatment effects on metabolic syndrome parameters in schizophrenia patients: preliminary results, 19th European Congress of Psychiatry, 01 Apr 2011

Masters Degree, Dr Nurul Azreen Bt Hashim, Depression and quality of life in patients with type 2 diabetes mellitus, 2010/2011

Masters Degree, Dr Mohd Fadzli Mohamad Isa, Sexual behaviour among amphetamine type stimulant users in Malaysian drug rehabilitation centre, 2010/2011

Masters Degree, Sim Maw Shin, Association between single nucleotide polymorphisms of various candidate genes with methamphetamine dependence in the Malaysian population, 2010/2011

Masters Degree, Dr Amer Siddiq Amer Nordin, Risk factors for depression after myocardial infarction, 2007/2008

Masters Degree, Dr Zuraida Ahmad Sabki, Case Protocol of Panic Disorder with Agaraophobia, 2006/2007

Masters Degree, Dr Mashitah, Prevalence of depression among patients with ischaemic heart disease, 2006/2007

Masters Degree, Dr Aminuddin, Risk factors of relapse among heroin addicts, 2006/2007

Masters Degree, Dr Rusdi Abd Rashid, Prevalence of depression and anxiety among heroin dependence, 2005/2006

Masters Degree, Dr John Tan Jin Teong, Service utilization and costs associated with switching to risperidone from previous treatment with typical antipsychotic agent, 2004/2005

Masters Degree, Dr Khoo Yee Laim, Case Protocol for Psychotherapy, 2004/2005

Masters Degree, Dr. Ting Joe Hang, Insight among patients with schizophrenia in Hospital Permai, 2003/2004

Masters Degree, Dr. Chin Loi Fei, Prescribing pattern of antidepressant and antipsychotic, 2003/2004

Masters Degree, Dr Subash Kumar Pillai, Psychiatric posting in final year medical students: do attitudes change?, 2002/2003

Masters Degree, Dr Sharmilla Kanagasundram, Insight among patients with schizophrenia, bipolar and depression, 2002/2003

Masters Degree, Dr. Parameswaran, Marital Therapy Case Protocol, 2001/2002

Masters Degree, Dr Mas Ayu Said, Risk factor for post-stroke depression, 2001/2002

Masters Degree, Dr Chin Soo Cheng, The outcomes in schizophrenia patients after switching from oral antipsychotic paliperidone, 2011/2012

Masters Degree, Dr Aisah Abdul Rahim, The safety and efficacy of escitalopram in the treatment of major depression among diabetis mellitus patients., 2011/2012

Patterns of antipsychotic use among hospitalized schizophrenic patients in UMMC / Bachelor of Pharmacy, 2006/2007, 1

Prevalence attitude and practice towards cigarette smoking among medical doctors in UMMC / MBBS, 2005/2006, 1

Body image concern among female university students / MBBS, 2005/2006, 1

Prevalence of Anxiety and depression among medical students / MBBS, 2003/2004, 4

Attitudes of paramedic towards patients with mental illness / MBBS, 2002/2003, 1

Consultant and Lectures, Substance Abuse Research Centre, Jazan University, Saudi Arabia., 2013, 12, (International)

Editorial Board Member, International Journal of Bipolar Disorders, 2012, 24, (International)

University Malaya Medical Centre Ethics Committee, University Malaya Medical Centre, Committee Member, 2012-2014, (University)

Ahli Majlis Unit Perundingan Universiti Malaya, University Malaya, Committee Member, 2012-2014

Trainer for PANSS and CGI scales, Bracket Global USA, Consultant , 2012-2012

Asia Bapineuzumab Advisory Board, Pfizer, Expert Advisor, 2012-2012, (International)

Master in Psychological Medicine, 2011/2012(1,2), 38, 500

Master in Psychological Medicine, 2010/2011(1,2), 35, 500

Master In Psychological Medicine, 2009/2010(1,2), 34, 500

Master In Psychological Medicine, 2008/2009(1,2), 32, 500

Phase 3B Psychiatry Posting, 2011/2012(1,2), 200, 336

Phase 3B Psychiatry Posting, 2010/2011(1,2), 200, 336

Phase 3B Psychiatry Posting, 2009/2010(1,2), 200, 336

Phase 3B Psychiatry Posting, 2008/2009(1,2), 200, 336

Kursus Bimbingan Program Sarjana Psikiatri 2012, (National), 16-Dec-12 until 18-Dec-12

Ahli Jawatankuasa Penganjur bagi Persidangan "International Society of Addiction Medicine Conference 2013", (International), 01-Jan-12 until 30-Jun-13

Presented Lecture during Bipolar Education Forum In Hong Kong, (International), 28-Oct-11 until 30-Oct-11

Lecture during Taiping Mental Health Conference, (National), 15-Oct-11 until 16-Oct-11

Public Lecture and Facilitator during Schizophrenia Relapse Prevention Forum, (National), 07-Oct-11 until 09-Oct-11

Invited as Panel Speaker in Talk Show "Nasi Lemak Kopi O" TV9, (National), 20-Feb-11 until 20-Feb-11

Lecture on "How to prepare FDA inspection", Fullerton Hotel, Singapore. 24 November 2009., (International), 24-Nov-09 until 24-Nov-09

Lecture on Management of Schizophrenia. Hospital Alor Star. 28 October 2009, (Government), 28-Oct-09 until 28-Oct-09

Lecture on Management of Depression. Hospital Bahagia Ulu Kinta. 30 July 2009., (Government), 30-Jul-09 until 30-Jul-09

Workshop on Treatment Resistant Schizophrenia. Hospital Penang. 12 May 2008, (Government), 12-May-08 until 12-May-08

Organizing Commitee: CINP Regional Conference 1 - 5 March 2008, KL Convention Centre, (International), 01-Mar-08 until 05-Mar-08

Public Lectures on Depression. Armada Hotel, Petaling Jaya. 15 July 2007, (Community), 15-Jul-07 until 15-Jul-07

Organizing Committee: 12th Malaysian Conference on Psychological Medicine, 24-26 Jun 2007. Park Royal Hotel Kuala Lumpur., (National), 24-Jun-07 until 27-Jun-07

Lecture on Stress Management at International Islamic University Malaysia, (Government), 27-Feb-07 until 27-Feb-07

Train the Trainer Workshop for Bipolar Psychoeducation. Le Meridien hotel, Kuala Lumpur. 4 March 2006, (Private), 04-Mar-06 until 04-Mar-06

Functionality in Schizophrenia Workshop. Hilton Hotel, Petaling Jaya. 22 January 2006., (National), 22-Jan-06 until 22-Jan-06

Schizoprenia Workshop for General Practitioners. 13 November 2005. Hilton Petaling Jaya, (National), 13-Nov-05 until 13-Nov-05

Lectures on Stress Management for Telekom Staff, (Private), 28-Sep-05 until 28-Sep-05

Organizing Committee: 10th Malaysian Conference on Psychological Medicine 24-26 Jun 2004, JW Marriot Hotel, Kuala Lumpur., (National), 24-Jun-04 until 26-Jun-04